Ainos, Inc. — Investor Relations & Filings
Filings indexed
992
across all filing types
Latest filing
2026-01-30
Major Shareholding Noti…
Country
US
United States of America
Listing
US
AIMD
Ainos, Inc. is a diversified medical technology company that integrates artificial intelligence with biotechnology to develop diagnostic and therapeutic solutions. A core focus is its proprietary "AI Nose" platform, a SmellTech technology that utilizes AI and advanced sensor arrays to detect and analyze Volatile Organic Compounds (VOCs) for diagnostic applications. In parallel, the company develops immune therapeutics, leveraging its extensive experience with low-dose interferon treatments and advancing SRNA-driven preventative medicine. Ainos also develops telehealth-compatible point-of-care testing (POCT) devices.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13D/A Filing | 2026-01-30 | English | |
| SCHEDULE 13D/A Filing | 2026-01-30 | English | |
| 4 Filing | 2026-01-29 | English | |
| SCHEDULE 13D Filing | 2026-01-27 | English | |
| 4 Filing | 2026-01-12 | English | |
| 8-K Filing | 2026-01-06 | English |
Browse filings by year
31 years- 2026 7 filings
- 2025 72 filings
- 2024 74 filings
- 2023 57 filings
- 2022 55 filings
- 2021 43 filings
- 2020 45 filings
- 2019 81 filings
- 2018 80 filings
- 2017 60 filings
- 2016 22 filings
- 2015 19 filings
- 2014 11 filings
- 2013 6 filings
- 2012 31 filings
- 2011 52 filings
- 2010 25 filings
- 2009 46 filings
- 2008 45 filings
- 2007 38 filings
- 2006 36 filings
- 2005 8 filings
- 2004 12 filings
- 2003 9 filings
- 2002 6 filings
- 2001 7 filings
- 2000 8 filings
- 1999 14 filings
- 1998 5 filings
- 1997 7 filings
- 1996 11 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 26255661 | SCHEDULE 13D/A Filing | 2026-01-30 | English | ||
| 26255656 | SCHEDULE 13D/A Filing | 2026-01-30 | English | ||
| 26255667 | 4 Filing | 2026-01-29 | English | ||
| 26255666 | SCHEDULE 13D Filing | 2026-01-27 | English | ||
| 26255703 | 4 Filing | 2026-01-12 | English | ||
| 26255662 | 8-K Filing | 2026-01-06 | English | ||
| 26255657 | 8-K Filing | 2026-01-05 | English | ||
|
2025
8 filings
| |||||
| 26255664 | 8-K Filing | 2025-12-31 | English | ||
| 10727951 | Major Shareholding Notification 2025 | 2025-11-28 | English | ||
| 10727950 | Major Shareholding Notification 2025 | 2025-11-28 | English | ||
| 10727949 | Major Shareholding Notification 2025 | 2025-11-28 | English | ||
| 10727948 | Major Shareholding Notification 2025 | 2025-11-28 | English | ||
| 10727952 | Director's Dealing 2025 | 2025-11-26 | English | ||
| 10727953 | Director's Dealing 2025 | 2025-11-26 | English | ||
| 10727954 | Director's Dealing 2025 | 2025-11-26 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
IMCB PJSC
Biotechnology company specializing in personal stem cell ba…
|
GEMA | RU | Professional, scientific and te… |
|
Immuneering Corp
Clinical-stage oncology company developing medicines using …
|
IMRX | US | Professional, scientific and te… |
|
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Clinical-stage biotech developing dual-approach immuno-onco…
|
1541 | HK | Professional, scientific and te… |
|
IMMUNIC, INC.
Develops oral small molecule therapies for chronic inflamma…
|
IMUX | US | Professional, scientific and te… |
|
Immunovant, Inc.
Clinical-stage immunology company developing anti-FcRn anti…
|
IMVT | US | Professional, scientific and te… |
|
IMMUPHARMA PLC
Specialty biopharmaceutical company developing peptide-base…
|
IMM | GB | Professional, scientific and te… |
|
IMMUTEP LIMITED
Develops LAG-3 targeting immunotherapies for cancer and aut…
|
IMM | AU | Professional, scientific and te… |
|
IMMUTEP Ltd
Biotechnology company developing LAG-3 immunotherapies for …
|
IMMP | US | Professional, scientific and te… |
|
IMPACT BIOMEDICAL INC.
Develops biopharmaceutical products and technologies to pro…
|
IBO | US | Professional, scientific and te… |
|
IMUGENE LIMITED
Clinical-stage immuno-oncology company developing cancer im…
|
IMU | AU | Professional, scientific and te… |
Ainos, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35040/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35040 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35040 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35040 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35040}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Ainos, Inc. (id: 35040)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.